A case study assessing the impact of M&A and licensing on FDA drug approvals of leading pharmaceutical companies
|
Author:
|
Schuhmacher, Alexander; Grinchenko, Kyrylo; Gassmann, Oliver; Hartl, Dominik; Hinder, Markus
|
|
Tübinger Autor(en):
|
|
|
Published in:
|
Drug Discovery Today
(2025), Bd.
30,
H.
3,
S.
104306
|
|
Verlagsangabe:
|
London : Elsevier Sci Ltd
|
|
Language:
|
English
|
|
Full text:
|
http://dx.doi.org/10.1016/j.drudis.2025.104306
|
|
ISSN:
|
1359-6446
|
|
DDC Classifikation:
|
610 - Medicine and health
|
|
Dokumentart:
|
Article
|
|
Show full item record
|
